We have demonstrated that the use of phosphoproteomics is a feasible and informative means of evaluating signaling responses to CXCL12 in CLL, which could be employed for investigating a variety of other stimuli in these or other primary cells. The gene discussed is CXCL12; the disease is B-cell chronic lymphocytic leukemia.